How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

VT

NASDAQ:VTVT
Get a brief AI stock analysisSaves ~ 15 minutes of your time

VT

vTv Therapeutics IncNASDAQ VTVT Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is VTVT undervalued compared to its fair value?

The fair value of VTVT stock is hidden USD. Relative to the market price of 20.4 USD vTv Therapeutics Inc is hidden.

vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. The company is ...[More about valuation]

vTv Therapeutics Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.054 $B

Price:

20.4 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-1.175

FINANCIALS

vTv Therapeutics financial for reporting period

Income Statement

0.001 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0056 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0049 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.001 B 100%
-0.0056 B -563%
-0.0049 B -487%

Balance Sheet

0.054 B
0.021 B

Financial Position Analysis

Assets

0.054 B
Current Assets
0.054 B
Total non-current assets
0.0003 B

Total current liabilities
0.0089 B
Total non-current liabilities
0.024 B

Cash Flow Statement

-0.0075 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0073 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

vTv Therapeutics fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-80 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is VTVT attractive for investment based on fundamental analysis?

VTVT stock rating is hidden. vTv Therapeutics is a hidden by Eyestock methodology.

Get VTVT Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

-2 061

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

2.262

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

VTVT analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for VTVT to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

vTv Therapeutics Inc competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

vTv Therapeutics Inc dividends

VTVT dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About VTVT stock

About the company vTv Therapeutics Inc

Market cap $B

0.054

Dividend yield

Shares outstanding

81.4836 B

vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. The company is headquartered in High Point, North Carolina and currently employs 13 full-time employees. The company went IPO on 2015-07-30. Its products pipeline includes TTP399, TTP273, HPP737 and HPP593. TTP399 is an orally administered, small molecule, liver-selective glucokinase activator (GKA) in development potential oral anti-diabetic for the treatment of type I diabetes. TTP399 completed the SimpliciT-I Study, a Phase II trial in patients with type I diabetes as an add-on to insulin therapy. Its HPP737 is an orally administered, non- central nervous system (CNS) penetrant phosphodiesterase type 4 (PDE4) inhibitor that addresses inflammatory diseases. TTP273 is an orally available, small molecule glucagon-like peptide 1 (GLP-1) receptor agonist, which is focused on treating postprandial hyperglycemia in cystic fibrosis related diabetes (CFRD) patients and cystic fibrosis patients. Its products pipeline also includes Nrf2/Bach1 Modulator Program.

VTVT profile

  • Ticker

    VTVT

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    30 July 2015

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    13

  • City

    High Point

  • Address

    3980 Premier Dr, Suite 310

  • Cusip

    918385105